Register for this webinar to explore actionable strategies that improve patient recruitment performance, optimize site selection, and engage the right patients.
In today’s complex clinical trial landscape, traditional site selection methods based solely on historical experience are no longer sufficient. Sponsors face increasing challenges in global trial execution, from navigating competitive environments to managing variable site performance. This webinar explores how integrating independent, holistic data with precision feasibility strategies can transform site enablement and patient recruitment, unlocking new levels of trial success.
Site enablement begins with understanding not just which sites have performed well in the past, but which are truly positioned to engage and recruit the right patients. By leveraging global insights into patient journeys and site engagement patterns, sponsors can identify high-performing sites and uncover untapped opportunities. This includes mapping patient pockets across geographies and understanding how patients interact with healthcare providers at various sites, which is critical for identifying diverse populations and non-investigator physicians who have access to eligible patients.
Patient recruitment driven by tokenized and longitudinal real-world data (RWD) enables unrivalled precision in targeting. This approach allows sponsors to pinpoint where patients are, when they appear and how best to reach them. But precision alone is not enough. The combination of data-driven insights with last-mile services, which directly engage patients and facilitate trial participation, is needed.
Attendees will gain a comprehensive view of how patient insights and feasibility capabilities support global trial planning, from identifying optimal sites to deploying recruitment strategies that scale. The featured speakers will highlight how independent data refreshes assumptions, validates site potential and supports confident decision-making. They will also showcase how precision targeting and patient engagement services converge to deliver measurable outcomes.
Skye Hodson, PhD
VP Clinical Solutions, Citeline
Skye is a Biochemist with over 10 years of life sciences CRO and CCO experience, delivering tangible business outcomes across strategy, product development, clinical operations, commercialization and growth. He focuses on leveraging enabling technologies to accelerate the development of new medicines, having seen firsthand how data-driven insights and advanced analytics/AI can unlock real value for patients and companies. He is passionate about disrupting the status quo and advancing holistic health agendas, engaging with the community as a speaker, mentor and advocate for innovation in life sciences.
Lindsay Stahl
VP, Global Head of Patient Engagement and Recruitment, Citeline
Lindsay leads Citeline's Patient Engagement and Recruitment division and is responsible for helping guide, grow, and deliver on our Patient Engagement and Recruitment solutions. She has over 15 years of experience in scientific and clinical research & development, and real-world data strategy and solutioning for clinical investigation.
Lindsay holds an MS in Epidemiology from Columbia University, an MA in Biopsychology from the City University of New York, Hunter, and a BA in Psychology from the University of Rhode Island